View
comments
An independent panel of experts will meet next week to determine whether COVID-19 vaccine booster shots should be available for people with weak immune systems.
The Advisory Committee on Immunization Practices will discuss the issue on July 22 and send recommendations to the Centers for Disease Control and Prevention (CDC).
This will affect between two and four percent of immunocompromised Americans who live with conditions including HIV/AIDS, cancer, diabetes or certain genetic disorders.
Studies have shown that some people with weakened immune systems are less likely to develop the same level of antibodies as others, leaving them potentially vulnerable to the virus.
No matter the recommendation made by the committee, the U.S. Food and Drug Administration will need to eventually approve a third dose of the vaccine.
Some health officials have said that there is no need for the third dose, though.
A CDC advisory panel will meet later this month to advise on whether a third dose of a COVID-19 vaccine should be recommended to immunocompromised people
Albert Bourla, CEO of Pfizer - the
